Q1 Clinical Consultants, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 5342 Us Hwy 301 North, Micro, NC 27555 Phone: 919-303-5377 Fax: 919-303-5380 |
News Archive
When Joyce Moss recently arrived at Loyola University Hospital with a life-threatening heart attack, it took just 42 minutes to perform an emergency balloon angioplasty.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.
Apricus Biosciences, Inc., announced today that the International Journal of Pharmaceutics, a peer reviewed journal, has published new data on the NexACT technology in their November 2010 issue, based on research conducted by, and at, the Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey in Piscataway, NJ.
Most patients who underwent laparoscopic appendectomy (surgical removal of the appendix) or cholecystectomy (surgical removal of the gallbladder) found virtual follow-up care more convenient than traditional in-person appointments, yet equally as satisfying, according to a study published as an "article in press" on the website of the Journal of the American College of Surgeons.
› Verified 4 days ago